
NTPC signs $750 billion foreign currency loan
NTPC Ltd
. has signed a foreign currency loan agreement worth $ 750 million with the IFSC Banking Units (IBUs) of
Bank of Baroda
and
HDFC Bank
, located in GIFT City, Gandhinagar. A NTPC statement said this unsecured, syndicated
External Commercial Borrowing
(ECB) facility comprises a base amount of $ 500 million and a greenshoe option of $ 250 million.
NTPC said proceeds from the facility will be utilized by the company to fund capital expenditure for ongoing and upcoming capacity addition programs, flue gas desulphurisation (FGD) projects, renewable energy and hydro-based projects. The power producer will also refinance existing ECBs, in line with the Reserve Bank of India's ECB Guidelines.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
All Senior Drivers Should Claim This Large Reward (Check If You Qualify)
Comparisons.org
Read More
Undo
Bank of Baroda and HDFC Bank acted as Mandated Lead Arrangers, underwriting $ 500 million (base amount by Bank of Baroda) and $ 250 million (greenshoe portion by HDFC Bank).
The loan has a door-to-door tenor of 10 years, with an average maturity of 7 years, the statement added.
This is the largest foreign currency lending by Bank of Baroda and the first-ever foreign currency loan extended by HDFC Bank to NTPC, the statement said.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


United News of India
9 hours ago
- United News of India
Sensex tumbles by 1,070.39 points during the week amid geopolitical tensions
Mumbai, June 14 (UNI) The BSE Sensex declined 1,070.39 points or 1.30 per cent to settle at 81,118.60, posting sharp losses during the week ended June 13, weighed down by geopolitical tensions, including the ongoing US-China trade talks and escalating hostilities between the US and Iran. Sentiment further deteriorated after Israel carried out military strikes on Iran, heightening tensions in the oil-rich Middle East. Investors will closely monitor crude oil prices, bond markets and further geopolitical developments. Nifty tumbled 284.45 points or 1.14 percent to settle at 24,718.60. The broader market outperformed the frontline indices. BSE Mid-Cap index shed 0.90 per cent to close at 45, Small-Cap fell 0.13 per cent to end at 53,370.29. On Monday Sensex added 256.22 points to settle at 82,445.21. Nifty, too, rose 100.15 points to 25,103.20. On Tuesday as investors closely monitored ongoing US-China trade discussions, sensex shed 53.49 points to 82,391.72. Nifty rose 1.05 points or 0.00% to 25,104.25. On Wednesday, buoyed by positive global trade developments, including encouraging signals from US-China trade negotiations in London, Sensex added 123.42 points to settle at 82,515.14. Nifty rose 37.15 points to 25,141.40. On Thursday, dragged down by shaky global cues and jittery investor sentiment, Sensex tanked 823.16 points to 81,691.98. Nifty slumped 253.20 points to 24,888.20. The domestic equity indices ended with significant losses on Friday, mirroring a sell-off across Asian markets, after Israel launched military strikes on Iran Sensex slumped 573.38 points to 81,118.60. Nifty fell 169.60 points to 24,718.60. Shares that fell during the week were HDFC Bank by 2.99 pc, JSW Steel by 1.69 pc Mahindra & Mahindra (M&M) by 3.19 pc, .Larsen & Toubro (L&T) by 0.47 pc, and Maruti Suzuki India by 0.82 pc Multi Commodity Exchange of India (MCX) jumped 2.23 pc . The company said it received approval from the Securities and Exchange Board of India (SEBI) to launch electricity derivatives. Capri Global Capital surged 13.2 pc The company launched the autopay facility for gold loans, eliminating the need for manual payments or branch visits Glenmark Pharmaceuticals rallied 5.09 pc. The drug maker announced the upcoming launch of zanubrutinib in India, following approval from the Drugs Controller General of India (DCGI). Zydus Lifesciences rose 1.47 pc. The company announced that it has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredient (API) manufacturing facility located at Dabhasa, near Vadodara. UNI JS PRS


Business Standard
11 hours ago
- Business Standard
NTPC to raise Rs 4,000 cr via 10-Year NCDs at 6.89%
NTPC said that its board has scheduled a meeting on 17 June 2025 to raise Rs 4,000 crore through debt securities on a private placement basis. The company plans to issue unsecured non-convertible debentures (NCDs) amounting to Rs 4,000 crore through private placement at a coupon of 6.89% p.a. The debentures will have a tenor of 10 years and 1 day, maturing on 18 June 2035. They are proposed to be listed on National Stock Exchange (NSE). Proceeds will be utilized for, inter alia, funding of capital expenditure, refinancing of existing loans and other general corporate purposes. Meanwhile, the companys Unit3 (660 MW) of North Karanpura Super Thermal Power Project (3x660 MW) declared commercial operation date (COD) with effect from 15 June 2025. NTPC is India's largest energy conglomerate. It has presence in the entire value chain of the power generation business. As of 31 March 2025, the Government of India held 51.10% stake in the company. The company had reported 23.4% increase in consolidated net profit to Rs 7,611.22 crore on a 4.6% rise in net sales to Rs 49,833.70 crore in Q4 FY25 compared with Q4 FY24. The counter shed 0.43% to end at Rs 332 on Friday, 13 June 2025.


Economic Times
18 hours ago
- Economic Times
Rising oil prices unlikely to impact inflation: Experts
Reuters Oil prices (Image for representation) The spike in crude oil prices amid escalating tensions between Israel and Iran is unlikely to impact retail inflation, which hit a 75-month low in May, experts noted, citing stable fuel prices in India. Brent crude price surged above $78 per barrel before settling around $74 per barrel on Friday, amid fears of supply disruptions following Israel's strike against Iran. "When the crude oil price declined to $60 per barrel, the government did not pass the benefit to the consumers, hence there won't be any impact on inflation," said Madan Sabnavis, chief economist at Bank of Baroda. During the recent period of low crude prices, the government had not cut retail gains from higher pump prices were shared among the government, state authorities and oil marketing companies (OMCs), meaning that current price increases will primarily affect these entities rather than consumers, said Sabnavis. "The risk to inflation remains low, as fuel prices have not changed for some time now," noted Gaura Sengupta, chief economist at IDFC First Bank. However, Paras Jasrai, associate director at India Ratings and Research, warned, "If the conflict between the two countries escalates further, then this could spring up crude oil price beyond $80/bbl, which can put a stop to the disinflationary trend that India has been witnessing".